IP Library Granted Patent US 11,457,937
Granted Patent B2
US 11,457,937 · App. 16/872,132 · Granted Oct 4, 2022

Subcutaneous wound debridement

Inventors: Jagjit Singh Gill (Rochester, MN); Lewis Hillel Freed (Scottsdale, AZ); Bernard Francis Morrey (Fayetteville, TX)
Assignee: Tenex Health, Inc.
A61B17/22012A61B17/320068A61B2217/005A61B2217/007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,457,937
App. No.
16/872,132
Granted
Oct 4, 2022
Kind
B2
Abstract

Disclosed herein are devices and methods of percutaneously treating an ulcerated wound using ultrasonic energy. Some methods include delivering ultrasonic energy to a target tissue located at a position subcutaneous to the ulcerated wound. In some methods, the ultrasonic energy is delivered using an ultrasonic energy delivery device.

Claims (19)

1. A method of delivering ultrasonic energy to a target tissue using an ultrasonic energy delivery device, the device comprising a transducer; an aspiration conduit; an irrigation conduit; a horn; and a needle, the method comprising:

creating at least two percutaneous access portals surrounding the target tissue;

inserting a distal portion of the needle to a first position subcutaneous to the target tissue using a first access portal of the percutaneous access portals and generating ultrasonic energy at the first subcutaneous position; then

inserting the distal portion of the needle to a second position subcutaneous to the target tissue through a second access portal of the percutaneous access portals and generating ultrasonic energy at the second subcutaneous position.

2. The method of claim 1 , wherein said target tissue is located subcutaneous to an ulcerated wound.

3. The method of claim 1 , further comprising debriding the target tissue with the ultrasonic energy.

4. The method of claim 3 , further comprising removing from the first subcutaneous position and/or the second subcutaneous position at least some detritus that may have been produced by the debriding.

5. The method of claim 1 , wherein the target tissue comprises at least one of the following: soft tissue and hard tissue.

6. The method of claim 1 , further comprising delivering fluid at the first subcutaneous position and/or the second subcutaneous position.

7. The method of claim 1 , wherein the ultrasonic energy is delivered through the needle.

8. The method of claim 1 , wherein the target tissue comprises a foot ulcer.

9. The method of claim 8 , wherein the target tissue located at the first subcutaneous position and/or the second subcutaneous position comprises ulcerated wound tissue.

10. The method of claim 8 , wherein the ulcerated wound tissue comprises bone tissue.

11. The method of claim 9 , wherein the ulcerated wound tissue comprises abnormal growth.

12. The method of claim 11 , wherein the abnormal growth comprises at least one of a bony prominence, calcific tissue, and necrotic tissue.

13. The method of claim 1 , wherein the needle is a fully hardened hypodermic needle.

14. The method of claim 13 , wherein the needle comprises a stainless steel material.

15. The method of claim 1 , wherein the needle includes an exposed portion having a length of about 0.75 inches to about 1.5 inches.

16. The method of claim 1 , wherein the needle has a gauge of about 12 to about 25.

Assignments (2)
SECURITY AGREEMENT Recorded Apr 1, 2021
From: TENEX HEALTH, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, LP
Reel/Frame 055811/0319 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2020
From: GILL, JAGJIT SINGH; FREED, LEWIS HILLEL; MORREY, BERNARD FRANCIS
To: TENEX HEALTH, INC.
Reel/Frame 052677/0001 →
Continuity (3)
Continuation 15973344 · May 7, 2018
Continuation 14475129 · Sep 2, 2014
Related Publication 20200268398A1 · Aug 27, 2020
Cited By (1)
US 12,667,377